Lazarescu, Or https://orcid.org/0000-0003-3640-873X
Ziv-Agam, Maya https://orcid.org/0000-0001-5355-8014
Haim, Yulia
Hekselman, Idan
Jubran, Juman https://orcid.org/0000-0002-7988-9214
Shneyour, Ariel https://orcid.org/0009-0006-3072-487X
Muallem, Habib
Zemer, Alon
Rosengarten-Levin, Marina
Kitsberg, Daniel
Levin, Liron
Liberty, Idit F.
Yoel, Uri https://orcid.org/0000-0003-3805-3565
Dukhno, Oleg
Adam, Miriam
Braune, Julia https://orcid.org/0000-0003-0460-1092
Müller, Claudia https://orcid.org/0000-0003-2670-5626
Raulien, Nora https://orcid.org/0000-0003-3097-5645
Gericke, Martin https://orcid.org/0000-0002-0792-5394
Körner, Antje https://orcid.org/0000-0001-6001-0356
Murphy, Rinki https://orcid.org/0000-0002-0043-2423
Blüher, Matthias
Habib, Naomi https://orcid.org/0000-0002-6049-2487
Rudich, Assaf https://orcid.org/0000-0002-1366-1444
Yeger-Lotem, Esti https://orcid.org/0000-0002-8279-7898
Article History
Received: 31 August 2023
Accepted: 25 November 2024
First Online: 24 January 2025
Competing interests
: M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiich-Sankyo, Lilly, Novo Nordisk, Novartis, Pfizer and Sanofi. All other authors declare no competing interests.